Dr. Marco Lavagnino is a distinguished professional in the pharmaceutical industry with over 28 years of experience at Bayer Pharmaceuticals, where he currently serves as the Medical Director for Cardiovascular and Renal. He has led regional and global projects, playing a key role in the development and implementation of medical strategies for cardiovascular products in Latin America. With extensive international experience and a strong track record in managing medical teams, Lavagnino is fluent in English, Spanish, and German. His academic background includes a Doctorate in Medicine from the University of El Salvador.